GoAI
Get started
Linical Co., Ltd. logo

Linical Co., Ltd.

2183.T

JPXHealthcareMedical - Diagnostics & Research

Open in GoAI

Latest quote

¥207

¥0.00 · 0.00%

Aug 24, 2:25 PM JSTData delayed

2183.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
JP
CEO
Kazuhiro Hatano
Listed since
Oct 27, 2008
Employees
577

Market position

Day range

Current ¥207

52-week range

Current ¥207

Open
¥207
Previous close
¥207
Volume
16.2K
0.5× average
Average volume
32.66K
Average daily volume
Market cap
4.68B JPY
Beta
0.38
Market reference 1
50-day average
¥208.14
-0.55% below average
200-day average
¥264.93
-21.86% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.85B JPY
P/E (TTM)
-1.23×
P/B (TTM)
1.46×
P/S (TTM)
0.59×
EV / EBITDA
-1.85×
Earnings yield
-57.36%
Free cash flow yield
-26.76%
Dividend yield
3.86%

Profitability & efficiency

Gross margin
1.50%
Operating margin
-33.81%
Net margin
-47.64%
Return on equity
-83.74%
Return on assets
-27.75%
Return on invested capital
-29.76%

Financial health

Debt / equity
0.63×
Current ratio
1.31×
Altman Z-score
0.63
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends38%10%-18%-45%Gross margin, FY2021: 28.90%Gross margin, FY2022: 30.70%Gross margin, FY2023: 27.88%Gross margin, FY2024: 19.24%Gross margin, FY2025: 8.69%Operating margin, FY2021: 9.40%Operating margin, FY2022: 10.04%Operating margin, FY2023: 5.90%Operating margin, FY2024: -5.59%Operating margin, FY2025: -23.92%Net margin, FY2021: 6.84%Net margin, FY2022: 8.02%Net margin, FY2023: 2.75%Net margin, FY2024: -5.17%Net margin, FY2025: -38.42%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 28.90%. Gross margin FY2022 30.70%. Gross margin FY2023 27.88%. Gross margin FY2024 19.24%. Gross margin FY2025 8.69%. Operating margin FY2021 9.40%. Operating margin FY2022 10.04%. Operating margin FY2023 5.90%. Operating margin FY2024 -5.59%. Operating margin FY2025 -23.92%. Net margin FY2021 6.84%. Net margin FY2022 8.02%. Net margin FY2023 2.75%. Net margin FY2024 -5.17%. Net margin FY2025 -38.42%.

Income trends

Revenue

8.67B JPY-16.97%

Operating income

−2.07B JPY-255.28%

Net income

−3.33B JPY-517.61%
Income trends across reported periods14.1B JPY7.76B JPY1.42B JPY−4.91B JPYRevenue, FY2021: 11.56B JPYRevenue, FY2022: 12.52B JPYRevenue, FY2023: 12.31B JPYRevenue, FY2024: 10.44B JPYRevenue, FY2025: 8.67B JPYOperating income, FY2021: 1.09B JPYOperating income, FY2022: 1.26B JPYOperating income, FY2023: 725.72M JPYOperating income, FY2024: −583.5M JPYOperating income, FY2025: −2.07B JPYNet income, FY2021: 790.49M JPYNet income, FY2022: 1B JPYNet income, FY2023: 338.27M JPYNet income, FY2024: −539.1M JPYNet income, FY2025: −3.33B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 11.56B JPY. Revenue FY2022 12.52B JPY. Revenue FY2023 12.31B JPY. Revenue FY2024 10.44B JPY. Revenue FY2025 8.67B JPY. Operating income FY2021 1.09B JPY. Operating income FY2022 1.26B JPY. Operating income FY2023 725.72M JPY. Operating income FY2024 −583.5M JPY. Operating income FY2025 −2.07B JPY. Net income FY2021 790.49M JPY. Net income FY2022 1B JPY. Net income FY2023 338.27M JPY. Net income FY2024 −539.1M JPY. Net income FY2025 −3.33B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue8.67B JPY10.44B JPY12.31B JPY12.52B JPY11.56B JPY
Cost of goods sold7.91B JPY8.43B JPY8.88B JPY8.67B JPY8.22B JPY
Gross profit753.13M JPY2.01B JPY3.43B JPY3.84B JPY3.34B JPY
Selling, general, and administrative2.83B JPY2.59B JPY2.71B JPY2.51B JPY2.19B JPY
Operating expenses2.83B JPY2.59B JPY2.71B JPY2.59B JPY2.25B JPY
Interest income44.95M JPY60.22M JPY52.27M JPY1.81M JPY598K JPY
Interest expense19.99M JPY16.87M JPY17.64M JPY12.83M JPY14.18M JPY
Depreciation and amortization534.23M JPY537M JPY521.51M JPY503.35M JPY458.78M JPY
Operating income−2.07B JPY−583.5M JPY725.72M JPY1.26B JPY1.09B JPY
Net income−3.33B JPY−539.1M JPY338.27M JPY1B JPY790.49M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-28.16

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-1.37-29.21-57.06-84.9Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 14, 2024: actual -8.78, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual -1.61, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 15, 2025: actual -9.84, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 14, 2025: actual -7.83, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual -33.24, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual -27.61, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual -78.73, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual -28.16, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.39B2.82B2.26B1.7BQ4 '24MissQ1 '25MissQ2 '25MissQ3 '25No estimateQ4 '25No estimateQ1 '26No estimateQ2 '26No estimateQ3 '26No estimate
Q4 2024, reported Nov 14, 2024: actual 2.5B JPY, estimate 3.06B JPY, surprise -18.35%, Miss. Q1 2025, reported Feb 14, 2025: actual 2.53B JPY, estimate 3.26B JPY, surprise -22.30%, Miss. Q2 2025, reported May 15, 2025: actual 2.48B JPY, estimate 3.14B JPY, surprise -20.83%, Miss. Q3 2025, reported Aug 14, 2025: actual 2.63B JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 2.23B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 13, 2026: actual 1.98B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 15, 2026: actual 1.83B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 14, 2026: actual 1.91B JPY, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥16.00

2025 complete year+14.3% since 2021

2026 partial: ¥8.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Mar 30, 2027

¥8.00

Annual

Record Mar 31, 2027 · Payment Mar 30, 2027

Dividend

Ex-dividend Mar 30, 2026

¥8.00

Annual

Record Mar 31, 2026 · Payment Jun 9, 2026

Dividend

Ex-dividend Mar 28, 2025

¥16.00

Annual

Record Mar 31, 2025 · Payment Jun 11, 2025

Dividend

Ex-dividend Mar 28, 2024

¥15.00

Annual

Record Mar 31, 2024 · Payment Jun 12, 2024

Dividend

Ex-dividend Mar 30, 2023

¥14.00

Annual

Record Mar 31, 2023 · Payment Jun 8, 2023

Dividend

Ex-dividend Mar 30, 2022

¥14.00

Annual

Record Mar 31, 2022 · Payment Jun 9, 2022

2183.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

Continue in GoAI

Research 2183.T

research.disclaimer